annanda-zhiyao-de-action-shiyan-zai-yingguo-shouwei-huanzhe-geiyao-hou-jinru-2-qi
type: WebPage
primary image of page: ImageObject
  caption: 安南达制药的 ACTiON 试验在英国首位患者给… | Cannabivo

安南达制药的 ACTiON 试验在英国首位患者给药后进入 2 期
type: NewsArticle
description: 安南达制药已在英国 NIHR 资助的 ACTiON 2 期试验中为首位患者给药，评估基于 CBD 的 MRX1 治疗化疗诱发性周围神经病变。
language: zh
main entity of page: https://cannabivo.com/zh/资讯/科学/annanda-zhiyao-de-action-shiyan-zai-yingguo-shouwei-huanzhe-geiyao-hou-jinru-2-qi
date published: 2026-07-23T23:51:14+00:00
date modified: 2026-07-23T23:51:14+00:00
article section: 科学
author: Rob Harley
  type: Person
  works for: Cannabivo
    type: Organization
  job title: Cannabivo 大麻政策与新闻撰稿人
  knows about: 大麻政策
  knows about: 监管
  knows about: 社交俱乐部
  knows about: 欧洲
publisher: Cannabivo
  type: Organization
word count: 300
speakable: SpeakableSpecification
  css selector: .research-article__title
  css selector: .research-article__lead

BreadcrumbList
item list element: 首页
  type: ListItem
  position: 1
  item: https://cannabivo.com/zh
item list element: 新闻
  type: ListItem
  position: 2
  item: https://cannabivo.com/zh/资讯
item list element: 科学
  type: ListItem
  position: 3
  item: https://cannabivo.com/zh/资讯/科学
item list element: 安南达制药的 ACTiON 试验在英国首位患者给药后进入 2 期
  type: ListItem
  position: 4
  item: https://cannabivo.com/zh/资讯/科学/annanda-zhiyao-de-action-shiyan-zai-yingguo-shouwei-huanzhe-geiyao-hou-jinru-2-qi

FAQPage
main entity: ACTiON 试验在研究什么？
  type: Question
  accepted answer: Answer
    text: ACTiON 是一项英国 2 期试验，正在评估安南达制药专有的基于 CBD 的口服溶液 MRX1，作为化疗诱发性周围神经病变的治疗。
main entity: 谁在领衔这项研究？
  type: Question
  accepted answer: Answer
    text: 该研究由苏格兰爱丁堡大学的玛丽·法伦教授领衔。
main entity: 这里的 NIHR 资助意味着什么？
  type: Question
  accepted answer: Answer
    text: ACTiON 研究获得了英国 NIHR 的疗效与机制评估资助。该资助为非稀释性资助，并在批准前接受独立科学审查。
main entity: MRX1 已被证明对 CIPN 有效吗？
  type: Question
  accepted answer: Answer
    text: 所给事实未报告疗效结果。此前的 1 期药代动力学试验在 20 名参与者中发现了良好的安全性表现，支持推进至 2 期。
main entity: 还有哪项 MRX1 研究正在进行？
  type: Question
  accepted answer: Answer
    text: ENDOCAN 是一项平行的 2 期研究，评估 MRX1 用于子宫内膜异位症相关疼痛。

Cannabivo
type: Organization
legal name: MS WebX L.L.C.
description: Cannabis club directory and information resource for social clubs in Europe.
contact point: ContactPoint
  contact type: Customer Support
address: PostalAddress
  street address: 7901 4th ST N STE 300
  postal code: 33702
  address locality: St. Petersburg
  address country: US
main entity of page: https://cannabivo.com/de/über-uns